Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

siRNA--getting the message out.

S H Lee1, P J Sinko

  • 1Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA.

European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|January 31, 2006
PubMed
Summary

Small interfering RNAs (siRNAs) enable gene silencing for studying drug transporters. While effective in vitro, in vivo delivery remains a challenge for research and therapeutic applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antiherpes simplex virus type 2 activity of the antimicrobial peptide subtilosin.

Journal of applied microbiology·2014
Same author

Toxicodynamics of rigid polystyrene microparticles on pulmonary gas exchange in mice: implications for microemboli-based drug delivery systems.

Toxicology and applied pharmacology·2012
Same author

Prodrug and conjugate drug delivery strategies for improving HIV/AIDS therapy.

Journal of drug delivery science and technology·2010
Same author

Drug selection in early drug development: screening for acceptable pharmacokinetic properties using combined in vitro and computational approaches.

Current opinion in drug discovery & development·2009
Same author

Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide.

Proceedings of the National Academy of Sciences of the United States of America·2005
Same author

Development of a novel intestinal and vascular access port (IVAP) rabbit model to study regiospecific oral absorption pharmacokinetics.

Comparative medicine·2002

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • RNA interference (RNAi) is a gene silencing mechanism utilizing double-stranded RNA (dsRNA).
  • Small interfering RNAs (siRNAs) are key effectors of RNAi, enabling sequence-specific gene knockdown.
  • siRNAs are established research tools in vitro for targeting drug transport proteins and metabolizing enzymes.

Purpose of the Study:

  • To review the background of siRNA technology.
  • To highlight the application of siRNAs in studying drug transporters and their role in ADME.
  • To discuss the potential of siRNAs as therapeutic agents.

Main Methods:

  • Review of existing literature on RNA interference and siRNA applications.
  • Discussion of challenges in in vivo siRNA delivery.
  • Examples of siRNA use in drug transporter research.

Main Results:

  • siRNA technology allows for precise gene knockdown of drug transporters and metabolizing enzymes.
  • In vitro applications of siRNAs are well-established.
  • In vivo delivery of siRNAs presents a significant challenge.

Conclusions:

  • siRNA offers a powerful tool for mechanistic studies of drug transporters, surpassing chemical inhibitors.
  • Further development is needed to overcome in vivo delivery hurdles for broader therapeutic and research applications.

Related Experiment Videos